2013 FDA Drug Approval Calendar
TheStreet.com
- Adcetris
- Amag Pharmaceuticals
- Amarin
- Antares
- Auxilium
- Aveo Pharmaceuticals
- Cubist Pharmaceuticals
- dabrafenib
- Delcath
- Depomed
- Dolutegravir
- drug approvals
- efinaconazole
- Entereg
- Feraheme
- Gilead
- GSK
- Melblez
- Merck
- Otrexup
- Seattle Genetics
- Sefelsa
- sofosbuvir
- suvorexant
- tivozanib
- Trametenib
- Valeant Pharmaceuticals
- Vascepa
- Xiaflex
- Zogenix
- Zohydro
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
Enhanced Online News
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
- Amag Pharmaceuticals
- Amarin
- Arena
- Ariad
- Biogen Idec
- Biomarin
- Celgene
- Clovis Oncology
- Dendreon
- Geron
- Gilead
- Human Genome Sciences
- Immunogen
- Incyte
- Indenix
- InterMune
- Keryx
- MannKind
- Medivation
- Merck KGaA
- Mesoblast
- ONYX Pharmaceuticals
- Regeneron
- Roche
- Seattle Genetics
- Spectrum Pharmaceuticals
- Vertex
- Vivus
- YM BioSciences
10 Biotech Stock Predictions for 2012
TheStreet.com

